A child born after the year 2000 has a 1 in 3 chance of developing diabetes in their lifetime. Additionally, most patients do not know they have a diagnosis for prediabetes. John Anderson, MD, talks about...
In one of the first clinical trials intended to compare the standard of care for diabetic foot wounds against EpiFix, a dehydrated human amnion/chorion membrane allograft (dHACM), researchers found...
Tricia Santos Cavaiola, MD, discussses concentrated insulin and its role as an important tool for managing severe insulin resistance in type-2 diabetes cases.
In this video, Dr Krysko discusses the findings from her study on the real-world effectiveness of newer vs injectable disease-modifying therapies among pediatric patients with multiple sclerosis.
